| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.28 | 0.02 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |